drugset / Trial / NCT06403670
Dexmedetomidine and Remifentanil in NORA
RandomizedParallel-groupDouble-blindTreatment
Summary
Endoscopic retrograde cholangiopancreatography (ERCP) procedure is frequently encountered in non-operating room anesthesia applications (NORA). It is a procedure that requires deep sedation and analgesia in terms of gastroenterologist and patient comfort. Dexmedetomidine, which is increasingly used in NORA applications, comes to the fore because it does not cause respiratory depression, reduces the stress response, and provides hemodynamic stability. This study aims to compare the effects of dexmedetomidine-propofol (DP) and remifentanil-propofol (RP) combinations on hemodynamic stability, rapid recovery, and patient comfort in patients who underwent ERCP.
Timeline
- Start
- 2022-12-17
- Primary completion
- 2024-04-30
- Completion
- 2024-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexmedetomidine | Other / unclassified | 0.1 ug/kg | Intravenous |
| Comparator | Dexmedetomidine | Other / unclassified | 0.7 ug/kg | Intravenous |
| Comparator | Remifentanil | Small molecule | 0.01 ug/kg | Intravenous |
| Comparator | Remifentanil | Small molecule | 0.1 ug/kg | Intravenous |
Indications
No indication recorded.